TTK Healthcare to study Reckitt-SSL deal impactJuly 22nd, 2010 - 8:14 pm ICT by IANS
Chennai, July 21 (IANS) TTK Healthcare will study the impact of Reckitt Benckiser’s acquisition of SSL International on the group, TTK officials said Thursday.
Consumer goods group Reckitt Benckiser Wednesday tied up
Durex condoms and Scholl sandals maker SSL in a $3.8 billion (£2.54 billion) deal to integrate it into its personal care division, the company’s fastest growing area.
TTK group officials said the overlap of distribution channels between the Indian arms of the two British companies and their rationalisation will have to be studied first.
SSL International has two joint ventures in India with the TTK group - one that makes Durex and Kohinoor brand of condoms (TTK LIG Ltd) and the other which makes the Scholl range of footcare products (SSL TTK Ltd).
Both the joint ventures, apart from meeting the domestic market needs, also cater to SSL’s global markets.
“SSL and Reckitt do not have any conflicting products in their portfolio. On the other hand, Reckitt will be adding new product categories like condoms to this product portfolio,” said the officials.
Production at the two companies may not be affected because SSL’s change of ownership, but the question that is being asked is on the impact on TTK Healthcare that distributes condoms and scholl range of footcare products.
Reckitt Benckiser sells products like Dettol, Harpic, mortein, Lizol, Cherry Blossom, Vanish, Easy-Off Bang, Veet, Colin, Disprin, Strepsils and Clearsil.
“The distribution may be realigned but the decision will be based on the economies and costs incurred by the respective companies,” a person close to the TTK group told IANS on the condition on anonymity.
“It will take sometime for the new owners to look at India and come down here to discuss the various modalities. Going by the history, the TTK group may even get more products to make here for the global markets,” he added.
According to him, there is no major overlap of outlets selling condoms and footcare products reached by TTK Healthcare and home and personal care products reached by Reckitt Benckiser.
For TTK Healthcare, distribution of consumer products is a loss-making proposition. Last year the company earned around Rs.95 crore and made a loss of Rs.1.52 crore.
When contacted by IANS, T.R. Venkatesh, managing director for TTK LIG and SSL TTK and who also heads the consumer products marketing, said: “All I can say now is no comments.”
- Dettol maker buys Durex condom manufacturer - Jul 21, 2010
- Reckitt Benckiser to acquire Paras Pharma for $728 mn - Dec 13, 2010
- Viagra in condom promises the lift - Dec 09, 2011
- TTK LIG to launch youth-focussed condoms - Apr 04, 2009
- Dengue spurs sales in mosquito repellents, launch of new products - Aug 29, 2010
- Brazil company recalls 620,000 condoms - Aug 25, 2012
- Durex launches e-store to increase condom sales - Oct 11, 2010
- Broadcasters, marketers - explore northeast states with 'Chrome NE' - Aug 02, 2011
- CSD500: Erection inducing condoms developed - May 10, 2011
- Erection inducing condom 'CSD500' might soon be available in Europe - May 10, 2011
- Condom use in China ballooning - Dec 02, 2009
- Female condom fails to gain popularity - Jul 03, 2012
- HLL Lifecare opens one-stop medical outlet in Kerala - Sep 30, 2011
- Eyeing small town India, subsidised condom set to be trendier - Jun 25, 2012
- Female condom yet to gain acceptability - Sep 11, 2012
Tags: change of ownership, cherry blossom, condoms, consumer goods, disprin, distribution channels, footcare products, global markets, harpic, joint ventures, lig, modalities, product portfolio, rationalisation, reckitt benckiser, scholl sandals, ssl international, strepsils, ttk healthcare, veet